Mergers and Acquisitions

WIL Research, a leading global Contract Research Organization (CRO) in the pharmaceutical, chemical and agrochemical industries, has acquired Ricerca Biosciences’ pharmaceutical services business located in Lyon, France. The addition of the 18,000-square meter facility fortifies WIL Research’s service offerings in Europe, strengthens its nonclinical safety assessment capability, and expands its portfolio of innovative specialty services.

This definitive acquisition will double WIL Research's capacity in Europe. Renamed WIL Research Europe - Lyon, the lab will retain its approximately 280 employees. Long-time Managing Director of the facility, Stéphane Bulle, will continue to lead the site and keep his current senior leadership team intact. Over the past 45 years, the Lyon facility has developed a strong scientific reputation with European pharmaceutical clients in safety pharmacology and specialized services including continuous infusion and developmental and reproductive toxicology.